REG3A and pancreatic adenocarcinoma: The binding of REG3A to the epidermal growth factor receptor (EGFR) was suggested given that the two moieties colocalize upon immunostaining of SW1990 pancreatic adenocarcinoma cells and EGFR/REG3A complexes are detected by co-immunoprecipitation (Liu et al., 2015).